Copyright
©The Author(s) 2018.
World J Transplantation. Sep 10, 2018; 8(5): 122-141
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.122
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.122
Figure 2 Spectrum of thrombotic microangiopathy[64].
AAV: ANCA-associated vasculitis; ADAMTS13: A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; aHUS: Atypical hemolytic uremic syndrome; C3G: C3 glomerulopathy; CAPS: Catastrophic antiphospholipid syndrome; cblC: Cobalamin C type; DGKE: Gene encoding diacylglycerol kinase ε; FH: Factor H; HELLP: Syndrome of hemolysis, elevated liver enzymes, and low platelets; HUS: Hemolytic uremic syndrome; IgAN: IgA nephropathy; MN: Membranous nephropathy; MPGN: Membranoproliferative GN; SRC: Scleroderma renal crisis; STEC: Shiga toxin–producing Escherichia coli; TMA: Thrombotic microangiopathy; TTP: Thrombotic thrombocytopenic purpura.
- Citation: Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141
- URL: https://www.wjgnet.com/2220-3230/full/v8/i5/122.htm
- DOI: https://dx.doi.org/10.5500/wjt.v8.i5.122